Classification of Myocardial 18 F-FDG PET Uptake Patterns Using Deep Learning

F 18 ( 18F) fluorodeoxyglucose (FDG) PET is used to evaluate cardiac tumors, inflammation, and myocardial viability. As a glucose analog, FDG is sensitive to carbohydrate metabolism, and increased FDG uptake implies a shift from lipid to carbohydrate metabolism. During fasting, the myocardium predominantly consumes free fatty acids and triglycerides with minimal carbohydrate metabolism (1). This metabolic pattern is reversed following a meal. Heart disease shows similar alterations in the metabolic shift from lipid to glucose metabolism (2), which has been attributed to the susceptibility of free fatty acid b-oxidation to ischemia (3–5). Nonischemic heart disease also shows increased carbohydrate usage (6,7). The shifting metabolism in normal myocardium and in patients with cardiac disease can result in different spatiotemporal uptake patterns at FDG PET (8). Investigators have spatially classified these patterns using several classification schemes from oncologic studies (9,10). The classification is qualitative, and there is variability among experts because of uncertainty and overlap in uptake patterns. There is a need for robust and automatic techniques to classify patterns of myocardial FDG PET uptake to improve consistency of diagnosis between patients with similar uptake patterns and among caregivers reviewing the same images. Likewise, fully automated segmentation and classification methods of left ventricle (LV) uptake patterns are needed to develop large-scale investigations of their clinical significance and to distinguish between physiologic and pathologic LV uptake. Such large-scale repositories are increasingly becoming available in health biobanks (11). There is a need for automated techniques to extract quantitative imaging traits such as myocardial uptake and pattern of classification from this imaging data at scale. To address the challenges of conventional analysis of large numbers of images and to improve the consistency of diagnosis, machine learning can provide precise image labeling using automation (12,13). Recent deep learning techniques have reached a high level of automated performance approaching or, in some cases, exceeding experts (14). An area to be explored is applying classification and

[1]  J. Kullberg,et al.  Validation of automated whole-body analysis of metabolic and morphological parameters from an integrated FDG-PET/MRI acquisition , 2020, Scientific Reports.

[2]  N. Tamaki,et al.  Prognostic Value of 18F-FDG PET Using Texture Analysis in Cardiac Sarcoidosis. , 2020, JACC. Cardiovascular imaging.

[3]  Jae Sung Lee,et al.  Multi-atlas cardiac PET segmentation. , 2019, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.

[4]  N. Tamaki,et al.  Use of 18F-FDG PET/CT texture analysis to diagnose cardiac sarcoidosis , 2018, European Journal of Nuclear Medicine and Molecular Imaging.

[5]  P. Donnelly,et al.  The UK Biobank resource with deep phenotyping and genomic data , 2018, Nature.

[6]  Jae Sung Lee,et al.  Improving the Accuracy of Simultaneously Reconstructed Activity and Attenuation Maps Using Deep Learning , 2018, The Journal of Nuclear Medicine.

[7]  Jae Sung Lee,et al.  Computed tomography super-resolution using deep convolutional neural network , 2018, Physics in medicine and biology.

[8]  Dong Young Lee,et al.  Adaptive template generation for amyloid PET using a deep learning approach , 2018, Human brain mapping.

[9]  Sanjay Ranka,et al.  Visual Explanations From Deep 3D Convolutional Neural Networks for Alzheimer's Disease Classification , 2018, AMIA.

[10]  Sebastian Thrun,et al.  Dermatologist-level classification of skin cancer with deep neural networks , 2017, Nature.

[11]  Subhashini Venugopalan,et al.  Development and Validation of a Deep Learning Algorithm for Detection of Diabetic Retinopathy in Retinal Fundus Photographs. , 2016, JAMA.

[12]  L. Emmett,et al.  Impact of Patient Preparation on the Diagnostic Performance of 18F-FDG PET in Cardiac Sarcoidosis: A Systematic Review and Meta-analysis , 2016, Clinical nuclear medicine.

[13]  Ida Häggström,et al.  PETSTEP: Generation of synthetic PET lesions for fast evaluation of segmentation methods , 2015, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.

[14]  M. Nishimura,et al.  The effects of 18-h fasting with low-carbohydrate diet preparation on suppressed physiological myocardial 18F-fluorodeoxyglucose (FDG) uptake and possible minimal effects of unfractionated heparin use in patients with suspected cardiac involvement sarcoidosis , 2015, Journal of Nuclear Cardiology.

[15]  Thomas Brox,et al.  U-Net: Convolutional Networks for Biomedical Image Segmentation , 2015, MICCAI.

[16]  Andrew Zisserman,et al.  Very Deep Convolutional Networks for Large-Scale Image Recognition , 2014, ICLR.

[17]  M. Moroi,et al.  Incidental focal FDG uptake in heart is a lighthouse for considering cardiac screening , 2013, Annals of Nuclear Medicine.

[18]  M. Gebregziabher,et al.  Effectiveness of prolonged fasting 18f-FDG PET-CT in the detection of cardiac sarcoidosis , 2009, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[19]  G. Sambuceti,et al.  Spatial and Temporal Heterogeneity of Regional Myocardial Uptake in Patients Without Heart Disease Under Fasting Conditions on Repeated Whole-Body 18F-FDG PET/CT , 2007, Journal of Nuclear Medicine.

[20]  Carl K Hoh,et al.  Clinical use of FDG PET. , 2007, Nuclear medicine and biology.

[21]  T. Yokoyama,et al.  Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[22]  T. Iwase,et al.  The physiological uptake pattern of (18)F-FDG in the left ventricular myocardium of patients without heart disease. , 2000, The journal of medical investigation : JMI.

[23]  K. Hayashida,et al.  Myocardial glucose metabolism in patients with hypertrophic cardiomyopathy: Assessment by F-18-FDG PET study , 1998, Annals of nuclear medicine.

[24]  E. Newsholme,et al.  The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. , 1963, Lancet.

[25]  Hamid Jafarkhani,et al.  A 3-D Active Contour Method for Automated Segmentation of the Left Ventricle From Magnetic Resonance Images , 2017, IEEE Transactions on Biomedical Engineering.

[26]  Nitish Srivastava,et al.  Dropout: a simple way to prevent neural networks from overfitting , 2014, J. Mach. Learn. Res..

[27]  Claudio Landoni,et al.  Presurgical identification of hibernating myocardium by combined use of technetium-99m hexakis 2-methoxyisobutylisonitrile single photon emission tomography and fluorine-18 fluoro-2-deoxy-d-glucose positron emission tomography in patients with coronary artery disease , 2004, European Journal of Nuclear Medicine.

[28]  J R Neely,et al.  Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle. , 1974, Annual review of physiology.